nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—Diclofenamide—glaucoma	0.0746	0.167	CbGbCtD
Bosentan—CYP2C9—Dorzolamide—glaucoma	0.0721	0.162	CbGbCtD
Bosentan—CYP2C9—Methazolamide—glaucoma	0.0642	0.144	CbGbCtD
Bosentan—CYP3A4—Pilocarpine—glaucoma	0.0553	0.124	CbGbCtD
Bosentan—CYP3A4—Brinzolamide—glaucoma	0.0434	0.0973	CbGbCtD
Bosentan—CYP3A4—Dorzolamide—glaucoma	0.0419	0.094	CbGbCtD
Bosentan—CYP3A4—Methazolamide—glaucoma	0.0373	0.0838	CbGbCtD
Bosentan—CYP3A4—Acetazolamide—glaucoma	0.0299	0.067	CbGbCtD
Bosentan—CYP3A4—Clonidine—glaucoma	0.027	0.0606	CbGbCtD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.0118	0.0878	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00842	0.0628	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00803	0.0599	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—MYLK—glaucoma	0.00614	0.0458	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00574	0.0429	CbGpPWpGaD
Bosentan—EDNRA—EGFR-dependent Endothelin signaling events—EDN1—glaucoma	0.005	0.0373	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—MYLK—glaucoma	0.00439	0.0328	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.00267	0.0199	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—EDN1—glaucoma	0.00247	0.0185	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—PTGFR—glaucoma	0.00236	0.0176	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—OPN4—glaucoma	0.00206	0.0154	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.00191	0.0143	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—PTGFR—glaucoma	0.00186	0.0139	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00184	0.0138	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—EDN1—glaucoma	0.00177	0.0132	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00174	0.013	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00166	0.0124	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00159	0.0119	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—NOS3—glaucoma	0.00151	0.0112	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00149	0.0111	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—OPN4—glaucoma	0.00148	0.011	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—EDN1—glaucoma	0.00147	0.011	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00146	0.0109	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00143	0.0107	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00138	0.0103	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00137	0.0102	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00133	0.00993	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—PTGFR—glaucoma	0.00133	0.00992	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00132	0.00985	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00125	0.00931	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—MMP1—glaucoma	0.00124	0.00924	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00123	0.00918	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—SMO—glaucoma	0.00119	0.0089	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00119	0.00887	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00114	0.00851	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—NOS3—glaucoma	0.00108	0.00805	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00106	0.00794	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—EDN1—glaucoma	0.00105	0.00787	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—OPN4—glaucoma	0.00104	0.00776	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00103	0.00767	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000977	0.00729	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—PTGFR—glaucoma	0.000936	0.00699	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—MMP1—glaucoma	0.000886	0.00662	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00088	0.00657	CbGpPWpGaD
Bosentan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000878	0.00655	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000858	0.0064	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—OPN4—glaucoma	0.000744	0.00555	CbGpPWpGaD
Bosentan—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000676	0.00504	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—PTGFR—glaucoma	0.00067	0.005	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—EDN1—glaucoma	0.000617	0.00461	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—EDN1—glaucoma	0.000609	0.00455	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—OPN4—glaucoma	0.000588	0.00439	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000552	0.00412	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—OPN4—glaucoma	0.000534	0.00398	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—C3—glaucoma	0.000532	0.00397	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PTGFR—glaucoma	0.000529	0.00395	CbGpPWpGaD
Bosentan—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000504	0.00376	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PTGFR—glaucoma	0.00048	0.00359	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—SMO—glaucoma	0.000472	0.00352	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00046	0.00343	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LRP12—glaucoma	0.000455	0.00339	CbGpPWpGaD
Bosentan—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000446	0.00333	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—EDN1—glaucoma	0.000442	0.0033	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—EDN1—glaucoma	0.000436	0.00326	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—OPN4—glaucoma	0.000421	0.00314	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000409	0.00305	CbGpPWpGaD
Bosentan—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000403	0.00301	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000395	0.00295	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—OPN4—glaucoma	0.000382	0.00285	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—C3—glaucoma	0.000381	0.00284	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PTGFR—glaucoma	0.000379	0.00283	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000357	0.00267	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000352	0.00262	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PTGFR—glaucoma	0.000344	0.00257	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—SMO—glaucoma	0.000338	0.00252	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000338	0.00252	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NARFL—glaucoma	0.000331	0.00247	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CA5A—glaucoma	0.000331	0.00247	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LRP12—glaucoma	0.000325	0.00243	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—OPN4—glaucoma	0.000315	0.00235	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—EDN1—glaucoma	0.000311	0.00232	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000303	0.00226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HEYL—glaucoma	0.000293	0.00219	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000293	0.00218	CbGpPWpGaD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000292	0.00218	CbGpPWpGaD
Bosentan—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000288	0.00215	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTGFR—glaucoma	0.000284	0.00212	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—C3—glaucoma	0.000272	0.00203	CbGpPWpGaD
Bosentan—Weight decreased—Timolol—glaucoma	0.00026	0.000619	CcSEcCtD
Bosentan—Pain—Travoprost—glaucoma	0.000259	0.000617	CcSEcCtD
Bosentan—Constipation—Travoprost—glaucoma	0.000259	0.000617	CcSEcCtD
Bosentan—Hyperglycaemia—Timolol—glaucoma	0.000259	0.000617	CcSEcCtD
Bosentan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000259	0.000615	CcSEcCtD
Bosentan—Paraesthesia—Pilocarpine—glaucoma	0.000258	0.000615	CcSEcCtD
Bosentan—Asthenia—Bimatoprost—glaucoma	0.000258	0.000615	CcSEcCtD
Bosentan—Fatigue—Brinzolamide—glaucoma	0.000258	0.000614	CcSEcCtD
Bosentan—Angioedema—Clonidine—glaucoma	0.000257	0.000612	CcSEcCtD
Bosentan—Dyspnoea—Pilocarpine—glaucoma	0.000257	0.000611	CcSEcCtD
Bosentan—Pain—Brinzolamide—glaucoma	0.000256	0.000609	CcSEcCtD
Bosentan—Somnolence—Pilocarpine—glaucoma	0.000256	0.000609	CcSEcCtD
Bosentan—Angiopathy—Betaxolol—glaucoma	0.000256	0.000608	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000256	0.00191	CbGpPWpGaD
Bosentan—Pruritus—Bimatoprost—glaucoma	0.000255	0.000606	CcSEcCtD
Bosentan—Immune system disorder—Betaxolol—glaucoma	0.000254	0.000605	CcSEcCtD
Bosentan—Diarrhoea—Apraclonidine—glaucoma	0.000254	0.000605	CcSEcCtD
Bosentan—Mediastinal disorder—Betaxolol—glaucoma	0.000254	0.000604	CcSEcCtD
Bosentan—Dyspepsia—Pilocarpine—glaucoma	0.000253	0.000603	CcSEcCtD
Bosentan—Chills—Betaxolol—glaucoma	0.000253	0.000601	CcSEcCtD
Bosentan—Syncope—Clonidine—glaucoma	0.000253	0.000601	CcSEcCtD
Bosentan—Decreased appetite—Pilocarpine—glaucoma	0.00025	0.000595	CcSEcCtD
Bosentan—Conjunctivitis—Timolol—glaucoma	0.000249	0.000593	CcSEcCtD
Bosentan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000249	0.000593	CcSEcCtD
Bosentan—Palpitations—Clonidine—glaucoma	0.000249	0.000592	CcSEcCtD
Bosentan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000249	0.000591	CcSEcCtD
Bosentan—Gastrointestinal pain—Travoprost—glaucoma	0.000248	0.00059	CcSEcCtD
Bosentan—Loss of consciousness—Clonidine—glaucoma	0.000248	0.000589	CcSEcCtD
Bosentan—Mental disorder—Betaxolol—glaucoma	0.000247	0.000587	CcSEcCtD
Bosentan—Pain—Pilocarpine—glaucoma	0.000246	0.000586	CcSEcCtD
Bosentan—Constipation—Pilocarpine—glaucoma	0.000246	0.000586	CcSEcCtD
Bosentan—Cough—Clonidine—glaucoma	0.000246	0.000585	CcSEcCtD
Bosentan—Dizziness—Apraclonidine—glaucoma	0.000246	0.000585	CcSEcCtD
Bosentan—Erythema—Betaxolol—glaucoma	0.000245	0.000583	CcSEcCtD
Bosentan—Malnutrition—Betaxolol—glaucoma	0.000245	0.000583	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—SMO—glaucoma	0.000242	0.00181	CbGpPWpGaD
Bosentan—Urticaria—Dorzolamide—glaucoma	0.000242	0.000576	CcSEcCtD
Bosentan—Epistaxis—Timolol—glaucoma	0.000242	0.000575	CcSEcCtD
Bosentan—Body temperature increased—Dorzolamide—glaucoma	0.000241	0.000573	CcSEcCtD
Bosentan—Abdominal pain—Dorzolamide—glaucoma	0.000241	0.000573	CcSEcCtD
Bosentan—Sinusitis—Timolol—glaucoma	0.00024	0.000572	CcSEcCtD
Bosentan—Chest pain—Clonidine—glaucoma	0.00024	0.000571	CcSEcCtD
Bosentan—Arthralgia—Clonidine—glaucoma	0.00024	0.000571	CcSEcCtD
Bosentan—Abdominal pain—Travoprost—glaucoma	0.00024	0.000571	CcSEcCtD
Bosentan—Anxiety—Clonidine—glaucoma	0.000239	0.000569	CcSEcCtD
Bosentan—Asthenia—Acetazolamide—glaucoma	0.000238	0.000567	CcSEcCtD
Bosentan—Dizziness—Bimatoprost—glaucoma	0.000238	0.000567	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000238	0.000567	CcSEcCtD
Bosentan—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000238	0.00178	CbGpPWpGaD
Bosentan—Urticaria—Brinzolamide—glaucoma	0.000238	0.000566	CcSEcCtD
Bosentan—Discomfort—Clonidine—glaucoma	0.000237	0.000564	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000237	0.00177	CbGpPWpGaD
Bosentan—Vomiting—Apraclonidine—glaucoma	0.000236	0.000562	CcSEcCtD
Bosentan—Muscle spasms—Betaxolol—glaucoma	0.000236	0.000561	CcSEcCtD
Bosentan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000235	0.00056	CcSEcCtD
Bosentan—Hypersensitivity—Brimonidine—glaucoma	0.000235	0.000559	CcSEcCtD
Bosentan—Dry mouth—Clonidine—glaucoma	0.000235	0.000558	CcSEcCtD
Bosentan—Bradycardia—Timolol—glaucoma	0.000234	0.000557	CcSEcCtD
Bosentan—Dermatitis—Apraclonidine—glaucoma	0.000234	0.000557	CcSEcCtD
Bosentan—Headache—Apraclonidine—glaucoma	0.000233	0.000554	CcSEcCtD
Bosentan—Vision blurred—Betaxolol—glaucoma	0.000231	0.00055	CcSEcCtD
Bosentan—Oedema—Clonidine—glaucoma	0.00023	0.000547	CcSEcCtD
Bosentan—Tremor—Betaxolol—glaucoma	0.00023	0.000547	CcSEcCtD
Bosentan—Asthenia—Brimonidine—glaucoma	0.000229	0.000545	CcSEcCtD
Bosentan—Infection—Clonidine—glaucoma	0.000228	0.000543	CcSEcCtD
Bosentan—Abdominal pain—Pilocarpine—glaucoma	0.000228	0.000541	CcSEcCtD
Bosentan—Body temperature increased—Pilocarpine—glaucoma	0.000228	0.000541	CcSEcCtD
Bosentan—Diarrhoea—Acetazolamide—glaucoma	0.000227	0.000541	CcSEcCtD
Bosentan—Rash—Bimatoprost—glaucoma	0.000227	0.00054	CcSEcCtD
Bosentan—Dermatitis—Bimatoprost—glaucoma	0.000227	0.00054	CcSEcCtD
Bosentan—Oedema peripheral—Timolol—glaucoma	0.000227	0.000539	CcSEcCtD
Bosentan—Anaemia—Betaxolol—glaucoma	0.000227	0.000539	CcSEcCtD
Bosentan—Shock—Clonidine—glaucoma	0.000226	0.000538	CcSEcCtD
Bosentan—Pruritus—Brimonidine—glaucoma	0.000226	0.000537	CcSEcCtD
Bosentan—Headache—Bimatoprost—glaucoma	0.000226	0.000537	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—OPN4—glaucoma	0.000226	0.00168	CbGpPWpGaD
Bosentan—Nervous system disorder—Clonidine—glaucoma	0.000225	0.000536	CcSEcCtD
Bosentan—Thrombocytopenia—Clonidine—glaucoma	0.000225	0.000536	CcSEcCtD
Bosentan—Hypersensitivity—Dorzolamide—glaucoma	0.000224	0.000534	CcSEcCtD
Bosentan—Tachycardia—Clonidine—glaucoma	0.000224	0.000534	CcSEcCtD
Bosentan—Hypersensitivity—Travoprost—glaucoma	0.000223	0.000532	CcSEcCtD
Bosentan—Skin disorder—Clonidine—glaucoma	0.000223	0.000531	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—EDN1—glaucoma	0.000223	0.00166	CbGpPWpGaD
Bosentan—Hyperhidrosis—Clonidine—glaucoma	0.000222	0.000529	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—RPTOR—glaucoma	0.000222	0.00166	CbGpPWpGaD
Bosentan—Nausea—Apraclonidine—glaucoma	0.000221	0.000525	CcSEcCtD
Bosentan—Hypersensitivity—Brinzolamide—glaucoma	0.000221	0.000525	CcSEcCtD
Bosentan—Vertigo—Betaxolol—glaucoma	0.00022	0.000524	CcSEcCtD
Bosentan—Syncope—Betaxolol—glaucoma	0.00022	0.000523	CcSEcCtD
Bosentan—Dizziness—Acetazolamide—glaucoma	0.00022	0.000523	CcSEcCtD
Bosentan—Anorexia—Clonidine—glaucoma	0.000219	0.000521	CcSEcCtD
Bosentan—Asthenia—Dorzolamide—glaucoma	0.000219	0.00052	CcSEcCtD
Bosentan—Asthenia—Travoprost—glaucoma	0.000218	0.000518	CcSEcCtD
Bosentan—Palpitations—Betaxolol—glaucoma	0.000217	0.000516	CcSEcCtD
Bosentan—Pruritus—Dorzolamide—glaucoma	0.000216	0.000513	CcSEcCtD
Bosentan—Loss of consciousness—Betaxolol—glaucoma	0.000216	0.000513	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NCK2—glaucoma	0.000215	0.00161	CbGpPWpGaD
Bosentan—Eye disorder—Timolol—glaucoma	0.000215	0.000512	CcSEcCtD
Bosentan—Asthenia—Brinzolamide—glaucoma	0.000215	0.000511	CcSEcCtD
Bosentan—Hypotension—Clonidine—glaucoma	0.000215	0.000511	CcSEcCtD
Bosentan—Pruritus—Travoprost—glaucoma	0.000215	0.000511	CcSEcCtD
Bosentan—Tinnitus—Timolol—glaucoma	0.000215	0.000511	CcSEcCtD
Bosentan—Cough—Betaxolol—glaucoma	0.000214	0.000509	CcSEcCtD
Bosentan—Nausea—Bimatoprost—glaucoma	0.000214	0.000509	CcSEcCtD
Bosentan—Cardiac disorder—Timolol—glaucoma	0.000214	0.000508	CcSEcCtD
Bosentan—Hypersensitivity—Pilocarpine—glaucoma	0.000212	0.000505	CcSEcCtD
Bosentan—Pruritus—Brinzolamide—glaucoma	0.000212	0.000504	CcSEcCtD
Bosentan—Vomiting—Acetazolamide—glaucoma	0.000211	0.000503	CcSEcCtD
Bosentan—Dizziness—Brimonidine—glaucoma	0.000211	0.000502	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—HEYL—glaucoma	0.00021	0.00157	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000209	0.000498	CcSEcCtD
Bosentan—Angiopathy—Timolol—glaucoma	0.000209	0.000497	CcSEcCtD
Bosentan—Chest pain—Betaxolol—glaucoma	0.000209	0.000497	CcSEcCtD
Bosentan—Arthralgia—Betaxolol—glaucoma	0.000209	0.000497	CcSEcCtD
Bosentan—Diarrhoea—Dorzolamide—glaucoma	0.000208	0.000496	CcSEcCtD
Bosentan—Headache—Acetazolamide—glaucoma	0.000208	0.000495	CcSEcCtD
Bosentan—Anxiety—Betaxolol—glaucoma	0.000208	0.000495	CcSEcCtD
Bosentan—Insomnia—Clonidine—glaucoma	0.000208	0.000495	CcSEcCtD
Bosentan—Immune system disorder—Timolol—glaucoma	0.000208	0.000495	CcSEcCtD
Bosentan—Diarrhoea—Travoprost—glaucoma	0.000208	0.000494	CcSEcCtD
Bosentan—Mediastinal disorder—Timolol—glaucoma	0.000207	0.000493	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000207	0.000493	CcSEcCtD
Bosentan—Asthenia—Pilocarpine—glaucoma	0.000207	0.000491	CcSEcCtD
Bosentan—Paraesthesia—Clonidine—glaucoma	0.000206	0.000491	CcSEcCtD
Bosentan—Discomfort—Betaxolol—glaucoma	0.000206	0.000491	CcSEcCtD
Bosentan—Dyspnoea—Clonidine—glaucoma	0.000205	0.000488	CcSEcCtD
Bosentan—Diarrhoea—Brinzolamide—glaucoma	0.000205	0.000488	CcSEcCtD
Bosentan—Somnolence—Clonidine—glaucoma	0.000204	0.000486	CcSEcCtD
Bosentan—Dry mouth—Betaxolol—glaucoma	0.000204	0.000486	CcSEcCtD
Bosentan—Pruritus—Pilocarpine—glaucoma	0.000204	0.000485	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PTGFR—glaucoma	0.000203	0.00152	CbGpPWpGaD
Bosentan—Mental disorder—Timolol—glaucoma	0.000202	0.00048	CcSEcCtD
Bosentan—Dizziness—Dorzolamide—glaucoma	0.000201	0.000479	CcSEcCtD
Bosentan—Rash—Brimonidine—glaucoma	0.000201	0.000479	CcSEcCtD
Bosentan—Dermatitis—Brimonidine—glaucoma	0.000201	0.000478	CcSEcCtD
Bosentan—Dizziness—Travoprost—glaucoma	0.000201	0.000477	CcSEcCtD
Bosentan—Malnutrition—Timolol—glaucoma	0.0002	0.000477	CcSEcCtD
Bosentan—Erythema—Timolol—glaucoma	0.0002	0.000477	CcSEcCtD
Bosentan—Oedema—Betaxolol—glaucoma	0.0002	0.000476	CcSEcCtD
Bosentan—Headache—Brimonidine—glaucoma	0.0002	0.000475	CcSEcCtD
Bosentan—Decreased appetite—Clonidine—glaucoma	0.0002	0.000475	CcSEcCtD
Bosentan—Infection—Betaxolol—glaucoma	0.000199	0.000473	CcSEcCtD
Bosentan—Gastrointestinal disorder—Clonidine—glaucoma	0.000198	0.000472	CcSEcCtD
Bosentan—Fatigue—Clonidine—glaucoma	0.000198	0.000472	CcSEcCtD
Bosentan—Dizziness—Brinzolamide—glaucoma	0.000198	0.000471	CcSEcCtD
Bosentan—Nausea—Acetazolamide—glaucoma	0.000197	0.00047	CcSEcCtD
Bosentan—Diarrhoea—Pilocarpine—glaucoma	0.000197	0.000469	CcSEcCtD
Bosentan—Shock—Betaxolol—glaucoma	0.000197	0.000468	CcSEcCtD
Bosentan—Pain—Clonidine—glaucoma	0.000197	0.000468	CcSEcCtD
Bosentan—Constipation—Clonidine—glaucoma	0.000197	0.000468	CcSEcCtD
Bosentan—Nervous system disorder—Betaxolol—glaucoma	0.000196	0.000467	CcSEcCtD
Bosentan—Thrombocytopenia—Betaxolol—glaucoma	0.000196	0.000466	CcSEcCtD
Bosentan—Tachycardia—Betaxolol—glaucoma	0.000195	0.000465	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—C3—glaucoma	0.000195	0.00145	CbGpPWpGaD
Bosentan—Skin disorder—Betaxolol—glaucoma	0.000194	0.000463	CcSEcCtD
Bosentan—Vomiting—Dorzolamide—glaucoma	0.000194	0.000461	CcSEcCtD
Bosentan—Hyperhidrosis—Betaxolol—glaucoma	0.000193	0.00046	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000192	0.00144	CbGpPWpGaD
Bosentan—Rash—Dorzolamide—glaucoma	0.000192	0.000457	CcSEcCtD
Bosentan—Dermatitis—Dorzolamide—glaucoma	0.000192	0.000457	CcSEcCtD
Bosentan—Rash—Travoprost—glaucoma	0.000191	0.000455	CcSEcCtD
Bosentan—Dermatitis—Travoprost—glaucoma	0.000191	0.000455	CcSEcCtD
Bosentan—Headache—Dorzolamide—glaucoma	0.000191	0.000454	CcSEcCtD
Bosentan—Anorexia—Betaxolol—glaucoma	0.000191	0.000454	CcSEcCtD
Bosentan—Vomiting—Brinzolamide—glaucoma	0.00019	0.000453	CcSEcCtD
Bosentan—Dizziness—Pilocarpine—glaucoma	0.00019	0.000453	CcSEcCtD
Bosentan—Headache—Travoprost—glaucoma	0.00019	0.000452	CcSEcCtD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00019	0.00142	CbGpPWpGaD
Bosentan—Nausea—Brimonidine—glaucoma	0.000189	0.000451	CcSEcCtD
Bosentan—Rash—Brinzolamide—glaucoma	0.000189	0.000449	CcSEcCtD
Bosentan—Vision blurred—Timolol—glaucoma	0.000189	0.000449	CcSEcCtD
Bosentan—Dermatitis—Brinzolamide—glaucoma	0.000189	0.000449	CcSEcCtD
Bosentan—Gastrointestinal pain—Clonidine—glaucoma	0.000188	0.000447	CcSEcCtD
Bosentan—Headache—Brinzolamide—glaucoma	0.000188	0.000446	CcSEcCtD
Bosentan—Hypotension—Betaxolol—glaucoma	0.000187	0.000445	CcSEcCtD
Bosentan—Angioedema—Timolol—glaucoma	0.000183	0.000436	CcSEcCtD
Bosentan—Vomiting—Pilocarpine—glaucoma	0.000183	0.000435	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—HDAC9—glaucoma	0.000183	0.00137	CbGpPWpGaD
Bosentan—Urticaria—Clonidine—glaucoma	0.000183	0.000435	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000182	0.000434	CcSEcCtD
Bosentan—Abdominal pain—Clonidine—glaucoma	0.000182	0.000432	CcSEcCtD
Bosentan—Body temperature increased—Clonidine—glaucoma	0.000182	0.000432	CcSEcCtD
Bosentan—Rash—Pilocarpine—glaucoma	0.000181	0.000432	CcSEcCtD
Bosentan—Dermatitis—Pilocarpine—glaucoma	0.000181	0.000431	CcSEcCtD
Bosentan—Insomnia—Betaxolol—glaucoma	0.000181	0.000431	CcSEcCtD
Bosentan—Nausea—Dorzolamide—glaucoma	0.000181	0.000431	CcSEcCtD
Bosentan—Headache—Pilocarpine—glaucoma	0.00018	0.000429	CcSEcCtD
Bosentan—Nausea—Travoprost—glaucoma	0.00018	0.000429	CcSEcCtD
Bosentan—Vertigo—Timolol—glaucoma	0.00018	0.000428	CcSEcCtD
Bosentan—Paraesthesia—Betaxolol—glaucoma	0.00018	0.000428	CcSEcCtD
Bosentan—Syncope—Timolol—glaucoma	0.00018	0.000427	CcSEcCtD
Bosentan—Dyspnoea—Betaxolol—glaucoma	0.000178	0.000425	CcSEcCtD
Bosentan—Nausea—Brinzolamide—glaucoma	0.000178	0.000423	CcSEcCtD
Bosentan—Palpitations—Timolol—glaucoma	0.000177	0.000421	CcSEcCtD
Bosentan—Dyspepsia—Betaxolol—glaucoma	0.000176	0.000419	CcSEcCtD
Bosentan—Loss of consciousness—Timolol—glaucoma	0.000176	0.000419	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—EDN1—glaucoma	0.000176	0.00131	CbGpPWpGaD
Bosentan—Cough—Timolol—glaucoma	0.000175	0.000416	CcSEcCtD
Bosentan—Decreased appetite—Betaxolol—glaucoma	0.000174	0.000414	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—SMO—glaucoma	0.000173	0.00129	CbGpPWpGaD
Bosentan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000173	0.000411	CcSEcCtD
Bosentan—Fatigue—Betaxolol—glaucoma	0.000173	0.000411	CcSEcCtD
Bosentan—Constipation—Betaxolol—glaucoma	0.000171	0.000407	CcSEcCtD
Bosentan—Pain—Betaxolol—glaucoma	0.000171	0.000407	CcSEcCtD
Bosentan—Nausea—Pilocarpine—glaucoma	0.000171	0.000407	CcSEcCtD
Bosentan—Arthralgia—Timolol—glaucoma	0.000171	0.000406	CcSEcCtD
Bosentan—Chest pain—Timolol—glaucoma	0.000171	0.000406	CcSEcCtD
Bosentan—Anxiety—Timolol—glaucoma	0.00017	0.000404	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000169	0.000403	CcSEcCtD
Bosentan—Hypersensitivity—Clonidine—glaucoma	0.000169	0.000403	CcSEcCtD
Bosentan—Discomfort—Timolol—glaucoma	0.000168	0.000401	CcSEcCtD
Bosentan—Dry mouth—Timolol—glaucoma	0.000167	0.000397	CcSEcCtD
Bosentan—Asthenia—Clonidine—glaucoma	0.000165	0.000392	CcSEcCtD
Bosentan—Oedema—Timolol—glaucoma	0.000163	0.000389	CcSEcCtD
Bosentan—Anaphylactic shock—Timolol—glaucoma	0.000163	0.000389	CcSEcCtD
Bosentan—Pruritus—Clonidine—glaucoma	0.000163	0.000387	CcSEcCtD
Bosentan—Infection—Timolol—glaucoma	0.000162	0.000386	CcSEcCtD
Bosentan—ABCB11—Metabolism—CA1—glaucoma	0.000162	0.00121	CbGpPWpGaD
Bosentan—Shock—Timolol—glaucoma	0.000161	0.000383	CcSEcCtD
Bosentan—Nervous system disorder—Timolol—glaucoma	0.00016	0.000381	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—EDN1—glaucoma	0.00016	0.00119	CbGpPWpGaD
Bosentan—Urticaria—Betaxolol—glaucoma	0.000159	0.000378	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—RPTOR—glaucoma	0.000159	0.00119	CbGpPWpGaD
Bosentan—Skin disorder—Timolol—glaucoma	0.000159	0.000378	CcSEcCtD
Bosentan—Body temperature increased—Betaxolol—glaucoma	0.000158	0.000376	CcSEcCtD
Bosentan—Hyperhidrosis—Timolol—glaucoma	0.000158	0.000376	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000158	0.00118	CbGpPWpGaD
Bosentan—Diarrhoea—Clonidine—glaucoma	0.000157	0.000374	CcSEcCtD
Bosentan—ABCB11—Metabolism—CTSA—glaucoma	0.000157	0.00117	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000156	0.00116	CbGpPWpGaD
Bosentan—Anorexia—Timolol—glaucoma	0.000156	0.000371	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—NCK2—glaucoma	0.000154	0.00115	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—C3—glaucoma	0.000154	0.00115	CbGpPWpGaD
Bosentan—Hypotension—Timolol—glaucoma	0.000153	0.000364	CcSEcCtD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000152	0.00114	CbGpPWpGaD
Bosentan—Dizziness—Clonidine—glaucoma	0.000152	0.000362	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Timolol—glaucoma	0.000149	0.000354	CcSEcCtD
Bosentan—Insomnia—Timolol—glaucoma	0.000148	0.000352	CcSEcCtD
Bosentan—ABCB11—Metabolism—CA2—glaucoma	0.000148	0.0011	CbGpPWpGaD
Bosentan—Hypersensitivity—Betaxolol—glaucoma	0.000147	0.000351	CcSEcCtD
Bosentan—Paraesthesia—Timolol—glaucoma	0.000147	0.000349	CcSEcCtD
Bosentan—Vomiting—Clonidine—glaucoma	0.000146	0.000348	CcSEcCtD
Bosentan—Dyspnoea—Timolol—glaucoma	0.000146	0.000347	CcSEcCtD
Bosentan—Somnolence—Timolol—glaucoma	0.000145	0.000346	CcSEcCtD
Bosentan—Rash—Clonidine—glaucoma	0.000145	0.000345	CcSEcCtD
Bosentan—Dermatitis—Clonidine—glaucoma	0.000145	0.000345	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000144	0.00108	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000144	0.00108	CbGpPWpGaD
Bosentan—Headache—Clonidine—glaucoma	0.000144	0.000343	CcSEcCtD
Bosentan—Dyspepsia—Timolol—glaucoma	0.000144	0.000342	CcSEcCtD
Bosentan—Asthenia—Betaxolol—glaucoma	0.000144	0.000342	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—SMO—glaucoma	0.000143	0.00107	CbGpPWpGaD
Bosentan—Decreased appetite—Timolol—glaucoma	0.000142	0.000338	CcSEcCtD
Bosentan—Pruritus—Betaxolol—glaucoma	0.000142	0.000337	CcSEcCtD
Bosentan—Gastrointestinal disorder—Timolol—glaucoma	0.000141	0.000336	CcSEcCtD
Bosentan—Fatigue—Timolol—glaucoma	0.000141	0.000335	CcSEcCtD
Bosentan—Pain—Timolol—glaucoma	0.00014	0.000333	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—C3—glaucoma	0.00014	0.00104	CbGpPWpGaD
Bosentan—Diarrhoea—Betaxolol—glaucoma	0.000137	0.000326	CcSEcCtD
Bosentan—Nausea—Clonidine—glaucoma	0.000137	0.000325	CcSEcCtD
Bosentan—Gastrointestinal pain—Timolol—glaucoma	0.000134	0.000318	CcSEcCtD
Bosentan—Dizziness—Betaxolol—glaucoma	0.000132	0.000315	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NTRK2—glaucoma	0.000131	0.000977	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HDAC9—glaucoma	0.000131	0.000977	CbGpPWpGaD
Bosentan—Urticaria—Timolol—glaucoma	0.00013	0.000309	CcSEcCtD
Bosentan—Abdominal pain—Timolol—glaucoma	0.000129	0.000308	CcSEcCtD
Bosentan—Body temperature increased—Timolol—glaucoma	0.000129	0.000308	CcSEcCtD
Bosentan—Vomiting—Betaxolol—glaucoma	0.000127	0.000303	CcSEcCtD
Bosentan—Rash—Betaxolol—glaucoma	0.000126	0.0003	CcSEcCtD
Bosentan—Dermatitis—Betaxolol—glaucoma	0.000126	0.0003	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—EDN1—glaucoma	0.000126	0.00094	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000126	0.000938	CbGpPWpGaD
Bosentan—Headache—Betaxolol—glaucoma	0.000125	0.000298	CcSEcCtD
Bosentan—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000124	0.000925	CbGpPWpGaD
Bosentan—Hypersensitivity—Timolol—glaucoma	0.00012	0.000287	CcSEcCtD
Bosentan—Nausea—Betaxolol—glaucoma	0.000119	0.000283	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000117	0.000876	CbGpPWpGaD
Bosentan—Asthenia—Timolol—glaucoma	0.000117	0.000279	CcSEcCtD
Bosentan—Pruritus—Timolol—glaucoma	0.000116	0.000275	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—EDN1—glaucoma	0.000114	0.000853	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NGFR—glaucoma	0.000112	0.000838	CbGpPWpGaD
Bosentan—Diarrhoea—Timolol—glaucoma	0.000112	0.000266	CcSEcCtD
Bosentan—CYP2C9—Metabolism—NARFL—glaucoma	0.000111	0.000825	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA5A—glaucoma	0.000111	0.000825	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—C3—glaucoma	0.00011	0.000821	CbGpPWpGaD
Bosentan—Dizziness—Timolol—glaucoma	0.000108	0.000257	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NTRK1—glaucoma	0.000107	0.000796	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TXN—glaucoma	0.000104	0.000777	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000104	0.000776	CbGpPWpGaD
Bosentan—Vomiting—Timolol—glaucoma	0.000104	0.000247	CcSEcCtD
Bosentan—Rash—Timolol—glaucoma	0.000103	0.000245	CcSEcCtD
Bosentan—Dermatitis—Timolol—glaucoma	0.000103	0.000245	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—SMO—glaucoma	0.000102	0.000765	CbGpPWpGaD
Bosentan—Headache—Timolol—glaucoma	0.000102	0.000244	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.0001	0.00075	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—C3—glaucoma	9.99e-05	0.000745	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	9.91e-05	0.000739	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN2B—glaucoma	9.83e-05	0.000734	CbGpPWpGaD
Bosentan—Nausea—Timolol—glaucoma	9.71e-05	0.000231	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.5e-05	0.000709	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EDN1—glaucoma	9.44e-05	0.000704	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.42e-05	0.000703	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NTRK2—glaucoma	9.37e-05	0.000699	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NGF—glaucoma	8.67e-05	0.000647	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	8.29e-05	0.000618	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—C3—glaucoma	8.24e-05	0.000615	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.17e-05	0.00061	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—glaucoma	8.08e-05	0.000603	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGFR—glaucoma	8.04e-05	0.0006	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOE—glaucoma	7.67e-05	0.000573	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NTRK1—glaucoma	7.64e-05	0.00057	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CAV1—glaucoma	7.6e-05	0.000567	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA5A—glaucoma	7.29e-05	0.000544	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NARFL—glaucoma	7.29e-05	0.000544	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FN1—glaucoma	7.24e-05	0.00054	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BAD—glaucoma	7.15e-05	0.000534	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN2B—glaucoma	7.04e-05	0.000525	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—glaucoma	6.75e-05	0.000504	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—glaucoma	6.62e-05	0.000494	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	6.53e-05	0.000488	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.51e-05	0.000486	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1B1—glaucoma	6.43e-05	0.00048	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCA1—glaucoma	6.43e-05	0.00048	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGF—glaucoma	6.21e-05	0.000463	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—C3—glaucoma	5.9e-05	0.00044	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—glaucoma	5.75e-05	0.000429	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOE—glaucoma	5.49e-05	0.00041	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CAV1—glaucoma	5.44e-05	0.000406	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA1—glaucoma	5.4e-05	0.000403	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTSA—glaucoma	5.23e-05	0.00039	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FN1—glaucoma	5.18e-05	0.000387	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—glaucoma	5.14e-05	0.000384	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BAD—glaucoma	5.12e-05	0.000382	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1B—glaucoma	4.98e-05	0.000372	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA2—glaucoma	4.94e-05	0.000368	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.82e-05	0.00036	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.82e-05	0.00036	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—glaucoma	4.61e-05	0.000344	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—glaucoma	4.55e-05	0.000339	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—glaucoma	4.23e-05	0.000316	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAV1—glaucoma	4.19e-05	0.000313	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—glaucoma	4.14e-05	0.000309	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—glaucoma	4.11e-05	0.000307	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1B—glaucoma	3.56e-05	0.000266	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA1—glaucoma	3.56e-05	0.000266	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TXN—glaucoma	3.48e-05	0.00026	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTSA—glaucoma	3.45e-05	0.000257	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—glaucoma	3.3e-05	0.000246	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA2—glaucoma	3.26e-05	0.000243	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.17e-05	0.000237	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—glaucoma	3.17e-05	0.000237	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.14e-05	0.000235	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—glaucoma	3.13e-05	0.000234	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—glaucoma	2.96e-05	0.000221	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—glaucoma	2.9e-05	0.000216	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—glaucoma	2.7e-05	0.000201	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TXN—glaucoma	2.29e-05	0.000171	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—glaucoma	2.24e-05	0.000167	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.17e-05	0.000162	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1B1—glaucoma	2.15e-05	0.00016	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCA1—glaucoma	2.15e-05	0.00016	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—glaucoma	1.78e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—glaucoma	1.72e-05	0.000128	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—glaucoma	1.52e-05	0.000113	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCA1—glaucoma	1.42e-05	0.000106	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1B1—glaucoma	1.42e-05	0.000106	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—glaucoma	1.41e-05	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAV1—glaucoma	1.4e-05	0.000105	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—glaucoma	1.13e-05	8.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—glaucoma	1.06e-05	7.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—glaucoma	1e-05	7.47e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—glaucoma	9.68e-06	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—glaucoma	9.32e-06	6.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAV1—glaucoma	9.23e-06	6.89e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—glaucoma	6.98e-06	5.21e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—glaucoma	6.39e-06	4.77e-05	CbGpPWpGaD
